WithdrawnNot Applicable

Impact of Nocturnal Hypoxemia on Glucose in High Altitude Sleep Disordered Breathing

Stopped: Changes in foreign component policy at NIH.

0Started 2025-12-01

Plain-language summary

Sleep disordered breathing is associated with impaired glucose tolerance and incident diabetes. Nocturnal hypoxemia is a potential stimulus of glucose intolerance. It is especially severe and highly prevalent in high altitude residents. Intervening on nocturnal hypoxemia may therefore improve glucose control and decrease the public health burden in high altitude populations. The objective of this study is to examine the impact of hypoxemia on glucose homeostasis in high altitude residents. The investigators will address this objective by examining the effect of supplemental oxygen on glucose in a randomized cross-over study.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Permanent residents of Puno, Peru Exclusion Criteria: * Recent travel to low altitude (\<3000 m) * Oxygen use * Pregnancy * Morbid obesity (BMI \> 40 kg/m2) * Current smoking * Diabetes * Other sleep disorders (e.g. circadian rhythm disorder or insomnia) * Use of open fires in the home (i.e. for cooking or heat) * Chronic Mountain Sickness (CMS) as defined by a daytime oxyhemoglobin saturation \< 85%, Qinghai CMS \>10 or excessive erythrocytosis as defined by hemoglobin \>19 g/dL in women or \>21 g/dL in men.

What they're measuring

Mean glucose level

Timeframe: 14 days after start of intervention

Trial details

NCT IDNCT05462834

SponsorJohns Hopkins University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-01

View on ClinicalTrials.gov More Sleep-Disordered Breathing trials